Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR. Kidney Int Rep. 2018;3:625–637

Autor: Brad Astor, Lawrence J. Appel, Adeera Levin, Ognjenka Djurdjev, Mila Tang, Sankar D. Navaneethan, Stacey E. Jolly, Jesse D. Schold, Joseph V. Nally, David C. Wheeler, Jonathan Emberson, John Townend, Martin Landray, Harold I. Feldman, Chi-yuan Hsu, James P. Lash, Philip A. Kalra, James P. Ritchie, Raman Maharajan, Helen Alderson, Beverly Lane, Kai-Uwe Eckardt, Markus P. Schneider, Anna Köttgen, Florian Kronenberg, Barbara Bärthlein, Alex R. Chang, Jamie A. Green, H. Lester Kirchner, Kevin Ho, Angharad Marks, Corri Black, Gordon J. Prescott, Nick Fluck, Masaaki Nakayama, Mariko Miyazaki, Tae Yamamoto, Gen Yamada, Angela Yee-Moon Wang, Sharon Cheung, Sharon Wong, Jessie Chu, Henry Wu, Varda Shalev, Gabriel Chodick, Peter J. Blankestijn, Jack F.M. Wetzels, Arjan D. van Zuilen, Jan A. van den Brand, Andrew S. Levey, Lesley A. Inker, Mark J. Sarnak, Hocine Tighiouart, Haitao Zhang, Benedicte Stengel, Pablo G. Rios, Nelson Mazzuchi, Liliana Gadola, Verónica Lamadrid, Laura Sola, John F. Collins, C. Raina Elley, Timothy Kenealy, Olivier Moranne, Cecile Couchoud, Cecile Vigneau, Nigel J. Brunskill, Rupert W. Major, David Shepherd, James F. Medcalf, Csaba P. Kovesdy, Kamyar Kalantar-Zadeh, Miklos Z. Molnar, Keiichi Sumida, Praveen K. Potukuchi, Hiddo J.L. Heerspink, Dick de Zeeuw, Barry Brenner, Juan Jesus Carrero, Peter Barany, Abdul Rashid Qureshi, Carl-Gustaf Elinder, Frank L.J. Visseren, Yolanda van der Graaf, Marie Evans, Maria Stendahl, Staffan Schön, Mårten Segelmark, Karl-Göran Prütz, David M. Naimark, Navdeep Tangri, Patrick B. Mark, Jamie P. Traynor, Colin C. Geddes, Peter C. Thomson, Josef Coresh, Ron T. Gansevoort, Morgan E. Grams, Kunihiro Matsushita, Mark Woodward, Luxia Zhang, Shoshana H. Ballew, Jingsha Chen, Lucia Kwak, Yingying Sang, Aditya Surapaneni, Brenda R. Hemmelgarn, Wolfgang C. Winkelmayer, John Davis, Danielle Green, Michael Cheung, Tanya Green, Melissa McMahan

Publikováno v: Kidney International Reports

The Chronic Kidney Disease (CKD) Prognosis Consortium is a collaborative author of the above-mentioned article. The CKD Prognosis Consortium investigators/collaborators are as follows: • African American Study of Kidney Disease and Hypertension (AA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eda6c23274da92e50eb1527772b16a5f
http://europepmc.org/articles/PMC6224632

CG223, a novel BET inhibitor, exerts TGF-β1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosis.

Autor: Kaneshita S; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. Electronic address: shunya-k@koto.kpu-m.ac.jp., Kida T; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. Electronic address: t-kida@koto.kpu-m.ac.jp., Yoshioka M; ConverGene LLC. 3093 Beverly Lane, Unit C, Cambridge, MD, 21613, United States. Electronic address: myoshioka@convergenepharma.com., Nishioka K; Department of Infectious Diseases, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. Electronic address: din85051@koto.kpu-m.ac.jp., Raje M; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 North Pine Street, Baltimore, MD, 21201, United States. Electronic address: mithun.raje@rosalindfranklin.edu., Sakashita A; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. Electronic address: aki0808@koto.kpu-m.ac.jp., Hirano A; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. Electronic address: tomiaiko@koto.kpu-m.ac.jp., Sagawa T; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. Electronic address: t-sagawa@koto.kpu-m.ac.jp., Kasahara A; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. Electronic address: matsusue@koto.kpu-m.ac.jp., Inoue T; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. Electronic address: tinoue@koto.kpu-m.ac.jp., Fujioka K; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. Electronic address: k-fjok@koto.kpu-m.ac.jp., Nagahara H; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. Electronic address: naaga@koto.kpu-m.ac.jp., Wada M; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. Electronic address: makoto-w@koto.kpu-m.ac.jp., Kohno M; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. Electronic address: mkohno@koto.kpu-m.ac.jp., Strovel JW; ConverGene LLC. 3093 Beverly Lane, Unit C, Cambridge, MD, 21613, United States. Electronic address: jstrovel@convergenepharma.com., Fletcher S; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 North Pine Street, Baltimore, MD, 21201, United States. Electronic address: steven.fletcher@rx.umaryland.edu., Ashihara E; Department of Clinical and Translational Physiology, Kyoto Pharmaceutical University, 5, Misasagi Nakauchi-cho, Yamashina-ku, Kyoto, 607-8414, Japan. Electronic address: ash@mb.kyoto-phu.ac.jp., Kawahito Y; Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465, Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. Electronic address: kawahity@koto.kpu-m.ac.jp.

Publikováno v: Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2021 Oct; Vol. 70, pp. 102057. Date of Electronic Publication: 2021 Aug 20.

Discovery and lead identification of quinazoline-based BRD4 inhibitors.

Autor: Yang SM; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, United States. Electronic address: yangs9@mail.nih.gov., Urban DJ; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, United States., Yoshioka M; ConverGene LLC., 3093 Beverly Lane, Unit C, Cambridge, MD 21613, United States., Strovel JW; ConverGene LLC., 3093 Beverly Lane, Unit C, Cambridge, MD 21613, United States., Fletcher S; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, 20 North Pine Street, Baltimore, MD 21201, United States., Wang AQ; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, United States., Xu X; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, United States., Shah P; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, United States., Hu X; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, United States., Hall MD; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, United States., Jadhav A; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, United States., Maloney DJ; National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, United States. Electronic address: dave@NexusDA.com.

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2018 Nov 15; Vol. 28 (21), pp. 3483-3488. Date of Electronic Publication: 2018 Aug 31.